Larvol Delta - At-the-upcoming-BIO-International-Convention-Cadrenal-will-present-a-dualtrack-portfolio-strategy-designed-to-maximize-value-for-potential-partners

tecarfarin (ATI-5923) - Cadrenal Therapeutics

CAD-1005 - Cadrenal Therapeutics

https://www.globenewswire.com/news-release/2026/06/18/3314211/0/en/cadrenal-therapeutics-to-file-for-fda-rare-pediatric-disease-designation-for-tecarfarin-in-kawasaki-disease.html

Jun 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next